Cecile Denis PhD

Cecile Denis concern the mechanisms of hemostasis, all the reactions that contribute to stopping bleeding and vascular integrity. From the beginning of his scientific career, in the late 1980s, interest Cécile Denis has focused on the study of hemorrhagic diseases and cardiovascular diseases. During his postdoctoral stay in the laboratory Denisa Wagner at Harvard Medical School in the United States, he has deepened this theme by developing biological models quite unique and dedicated to the study of von Willebrand factor, a protein necessary for the interrupt bleeding. The Willebrand disease patients suffering from bleeding disorders. This syndrome is the most frequent Constitutional hemorrhagic disease worldwide since in its moderate form, it affects up to 1% of the population.